UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairment. Pain Pract. 2025
13 Feb 2025
Datta I, Erridge S, Holvey C, Coomber R, Guru R, Holden W, Darweish Medniuk A, Sajad M, Searle R, Usmani A, Varma S, Rucker JJ, Platt M, Sodergren MH. UK […]
UK medical cannabis registry: an updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2024 Dec;18(12):829-838.
13 Feb 2025
Gupta A, Erridge S, Graf V, Kelada M, Bapir L, Jesuraj N, Warner-Levy J, Clarke E, McLachlan K, Coomber R, Rucker JJ, Platt MW, Sodergren MH. UK medical cannabis registry: […]
UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Cancer Pain. J Pain Palliat Care Pharmacother. 2025
13 Feb 2025
Varadpande M, Erridge S, Aggarwal A, Cowley I, Evans L, Clarke E, McLachlan K, Coomber R, Rucker JJ, Platt MW, Khan S, Sodergren M. UK Medical Cannabis Registry: An Analysis […]
The relationship between cannabis and anorexia nervosa: a scoping review. J Eat Disord. 2023
02 Oct 2024
Rogers CI, Pacanowski CR. The relationship between cannabis and anorexia nervosa: a scoping review. J Eat Disord. 2023 Oct 19;11(1):186. doi: 10.1186/s40337-023-00887-9. PMID: 37858278; PMCID: PMC10585887. https://ncbi.nlm.nih.gov/pmc/articles/PMC10585887
Cannabis-Impaired driving: ethical considerations for the primary care practitioner. Ann Med. 2023
02 Oct 2024
Huerne K, Ells C, Grad R, Filion KB, Eisenberg MJ. Cannabis-Impaired driving: ethical considerations for the primary care practitioner. Ann Med. 2023 Dec;55(1):24-33. doi: 10.1080/07853890.2022.2151716. PMID: 36444881; PMCID: PMC9718556. https://www.tandfonline.com/doi/full/10.1080/07853890.2022.2151716
Hemp & Cannabidiol: What is a Medicine?
02 Oct 2024
Hilderbrand RL. Hemp & Cannabidiol: What is a Medicine? Mo Med. 2018 Jul-Aug;115(4):306-309. PMID: 30228748; PMCID: PMC6140266. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140266
Psychiatric Disorders and Cannabinoid Receptors. Adv Exp Med Biol. 2021
02 Oct 2024
Joshi N, Onaivi ES. Psychiatric Disorders and Cannabinoid Receptors. Adv Exp Med Biol. 2021;1264:131-153. doi: 10.1007/978-3-030-57369-0_9. PMID: 33332008; PMCID: PMC10810008. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810008
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years. Pharmacol Rev. 2023
02 Oct 2024
Maccarrone M, Di Marzo V, Gertsch J, Grether U, Howlett AC, Hua T, Makriyannis A, Piomelli D, Ueda N, van der Stelt M. Goods and Bads of the Endocannabinoid System […]
Cannabis as a Source of Approved Drugs: A New Look at an Old Problem. Molecules. 2023
02 Oct 2024
Gabarin A, Yarmolinsky L, Budovsky A, Khalfin B, Ben-Shabat S. Cannabis as a Source of Approved Drugs: A New Look at an Old Problem. Molecules. 2023 Nov 21;28(23):7686. doi: 10.3390/molecules28237686. […]
Cannabis Use, Lung Cancer, and Related Issues. J Thorac Oncol. 2018
02 Oct 2024
Jett J, Stone E, Warren G, Cummings KM. Cannabis Use, Lung Cancer, and Related Issues. J Thorac Oncol. 2018 Apr;13(4):480-487. doi: 10.1016/j.jtho.2017.12.013. Epub 2018 Jan 31. PMID: 29374567. https://www.jto.org/article/S1556-0864(18)30038-8/fulltext
Development of Delivery Systems with Prebiotic and Neuroprotective Potential of Industrial-Grade Cannabis sativa L.Molecules. 2024 J
02 Oct 2024
Sip S, Stasiłowicz-Krzemień A, Sip A, Szulc P, Neumann M, Kryszak A, Cielecka-Piontek J. Development of Delivery Systems with Prebiotic and Neuroprotective Potential of Industrial-Grade Cannabis sativa L. Molecules. 2024 Jul 29;29(15):3574. […]
The Cannabis Terpenes.Molecules. 2020
02 Oct 2024
Sommano SR, Chittasupho C, Ruksiriwanich W, Jantrawut P. The Cannabis Terpenes. Molecules. 2020 Dec 8;25(24):5792. doi: 10.3390/molecules25245792. PMID: 33302574; PMCID: PMC7763918. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763918/pdf/molecules-25-05792.pdf